HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ophthalmic artery peak systolic velocity ratio distinguishes pre-eclampsia from chronic and gestational hypertension: A prospective cohort study.

AbstractOBJECTIVE:
To examine whether the ophthalmic artery peak systolic velocity ratio (OA PSV-ratio) is higher in women with pre-eclampsia compared with gestational hypertension (GH) and chronic hypertension (CH), after controlling for confounding variables.
DESIGN:
Prospective cohort.
SETTING:
Specialist hypertension clinic in a tertiary referral centre.
POPULATION:
Singleton pregnancies presenting between 32+0 and 36+6  weeks of gestation with pre-eclampsia (n = 50), GH (n = 54) and CH (n = 56).
METHODS:
Paired measurements of maternal mean arterial pressure (MAP) and OA PSV-ratio were performed by trained sonographers. Multiple linear regression was fitted to the OA PSV-ratio, including maternal characteristics and medical history, GH, pre-eclampsia and MAP and use of antihypertensive medication.
MAIN OUTCOME MEASURE:
Whether pre-eclampsia is independently associated with higher OA PSV-ratio.
RESULTS:
MAP was significantly higher in both GH (p = 0.0015) and pre-eclampsia (p = 0.008) than in CH pregnancies. There was no significant difference between pre-eclampsia and GH (0.670). The OA PSV-ratio was significantly higher in pre-eclampsia than CH (p = 0.0008) and GH (p = 0.015). There was no significant difference between the OA PSV-ratio in CH and GH (p = 0.352). Multiple linear regression modelling showed that the OA PSV-ratio was influenced by maternal weight (p = 0.005), maternal age (p = 0.014), antihypertensive medications (p = 0.007) and MAP (p < 0.0001). After controlling for these variables, the OA PSV-ratio was still significantly higher in those with pre-eclampsia (p = 0.0002).
CONCLUSIONS:
The OA PSV-ratio is influenced by maternal weight, age, antihypertensive medications and MAP. Pre-eclampsia is an independent predictor of OA PSV-ratio, which therefore may be a useful point-of-care test when assessing women presenting with hypertension.
AuthorsKatherine G Y Lau, Allan Wright, Emmanouil Kountouris, Kypros H Nicolaides, Nikos A Kametas
JournalBJOG : an international journal of obstetrics and gynaecology (BJOG) Vol. 129 Issue 8 Pg. 1386-1393 (07 2022) ISSN: 1471-0528 [Electronic] England
PMID34913252 (Publication Type: Journal Article)
Copyright© 2021 John Wiley & Sons Ltd.
Chemical References
  • Antihypertensive Agents
Topics
  • Antihypertensive Agents
  • Cohort Studies
  • Female
  • Gestational Age
  • Humans
  • Hypertension, Pregnancy-Induced (diagnosis)
  • Ophthalmic Artery (diagnostic imaging)
  • Pre-Eclampsia (diagnosis)
  • Pregnancy
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: